These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7200183)

  • 1. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
    Fields JZ; Gordon JH
    Life Sci; 1982 Jan; 30(3):229-34. PubMed ID: 7200183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W; Curtin J; Fields J
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prolyl-leucyl-glycinamide and cyclo(leucyl-glycine) on the supersensitivity of dopamine receptors in brain induced by chronic administration of haloperidol to rats.
    Bhargava HN
    Neuropharmacology; 1984 Apr; 23(4):439-44. PubMed ID: 6145116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM; Lane JD; Brauchi JT
    Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase.
    Bhargava HN
    Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH; Diamond BI
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats.
    Frey JM; Morgan WW; Ticku MK; Huffman RD
    Pharmacol Biochem Behav; 1987 Apr; 26(4):661-9. PubMed ID: 3602028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dose and duration of chronic pimozide administration on dopamine receptor supersensitivity.
    Dewey KJ; Fibiger HC
    Naunyn Schmiedebergs Arch Pharmacol; 1983 May; 322(4):261-70. PubMed ID: 6683359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ; Boucher R; Daigle M; Di Paolo T
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H; Kazi MS; Carino MA; Horita A
    Life Sci; 1982 Mar; 30(10):821-6. PubMed ID: 7200179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen in experimental tardive dyskinesia.
    Gordon JH; Borison RL; Diamond BI
    Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
    Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E
    Psychopharmacology (Berl); 1982; 76(3):222-7. PubMed ID: 6808540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain.
    Reches A; Wagner HR; Jiang D; Jackson V; Fahn S
    Life Sci; 1982 Jul; 31(1):37-44. PubMed ID: 7109853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophysectomy induced hypersensitivity to dopamine: antagonism by estrogen.
    Perry KO; Diamond BI; Fields JZ; Gordon JH
    Brain Res; 1981 Dec; 226(1-2):211-9. PubMed ID: 7197571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.